相关实验视频
Updated: Jul 15, 2025
07:01
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
85.0K
雌激素受体β影响结直肠癌细胞的低氧反应
Agnieszka Anna Rawłuszko-Wieczorek1, Julia Lipowicz1, Marta Nowacka1
1Department of Histology, Poznań University of Medical Sciences, Poland.
Biochimica et biophysica acta. Molecular basis of disease
|September 25, 2023
概括
雌激素受体β (ERβ) 的存在抑制了结直肠癌 (CRC) 的生长,并抑制了CRC细胞中的缺氧反应. 这个受体这个受体.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 大肠直肠癌 (CRC) 的发生与雌激素受体β (ERβ) 的存在相反相关.
- 低ERβ表达与CRC患者的整体存活率较差有关.
- 瘤缺氧与固体瘤的预后和治疗阻力降低有关.
研究的目的:
- 研究ERβ在抑制结直肠癌细胞中低氧反应中的作用.
- 阐明ERβ影响CRC中缺氧相关基因表达的分子机制.
主要方法:
- 在常态和缺氧条件下,过度表达ERβ的HCT116细胞的高通量转录概况.
- 在DLD-1细胞中使用时间过程实验验验证基因表达变化 (VEGFA,PDGFA,ANGPTL4).
- 评估ERβ在调节基因表达中的DNA结合域功能.
- 分析ERβ对低氧调节剂HIF1A在转录和转化水平的表达的影响.
主要成果:
- 在低氧状态下,ERβ过度表达显著改变了CRC细胞的转录特征.
- ERβ抑制了关键的低氧相关基因的表达,包括VEGFA,PDGFA和ANGPTL4.
- ERβ的基因下调作用取决于它直接与调节区域结合.
- ERβ影响了HIF1A的表达,HIF1A是低氧的主要调节者.
结论:
- 雌激素受体β (ERβ) 在抑制结直肠癌细胞中低氧反应方面发挥着重要作用.
- ERβ直接调节低氧相关基因,影响瘤进展和潜在的治疗结果.
- 在CRC中,ERβ代表了调节低氧瘤微环境的潜在治疗标.
相关概念视频
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
01:24Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
01:22Target Cell Response to Hormones
3.1K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
3.1K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
01:23Hypoxia
1.1K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.1K
01:31Transducer Mechanism: Nuclear Receptors
1.4K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.4K